| http://www.w3.org/ns/prov#value | - Recently, Gilead Sciences Inc. announced that they will raise the prices of several of its top selling HIV medications Atripla (5.1%), Turvada, and Emtriva (7.9%). ???Price increases like the ones Gilead announced ??? on top of 2009 and 2010 increases??? are unreasonable, particularly in light of the fact that Atripla, Truvada and Emtriva are older drugs that contain no new formulations,??? said M
|
